PharmaliZr Glossary

protocol that allows different applications to communicate with each other using a defined set of rules. PharmaliZr offers a RestFull API that allows interoperability with your Hospital Information System (HIS).

wireless scanner that can read barcodes, including Datamatrix. The Zebra DS2278-SR scanner is compatible with PharmaliZr and can be used to scan medicines during serialization operations.

public software distribution market offered by the Hospital IT Purchasing Center (CAIH). It allows healthcare facilities to access more than 400 software solutions negotiated under the best conditions. PharmaliZr is part of the ELODI catalog.

design system developed by Google, which allows creating simple, intuitive and responsive graphical interfaces. PharmaliZr uses Material Design V2 to offer an optimal user experience.

software distribution model that involves the user installing the software on their own server or IT environment. PharmaliZr can be deployed in On-Premise mode for facilities that wish to do so.

(software as a service): cloud-based service that provides access to applications via the internet, without having to install them on the user's computer. PharmaliZr is a SaaS software that offers a turnkey solution for medicine traceability.

public purchasing center that offers public buyers products and services in various fields. PharmaliZr is among the software solutions selected by UGAP for drug serialization.

messages generated by the verification system when the control or deactivation of a medicine fails or presents an anomaly. Alerts must be handled by users or by competent authorities depending on the case.

two-dimensional barcode that contains the unique identifier of the medicine. The DataMatrix code must be scanned at different stages of the medicine circuit.

action that consists of making the unique identifier of a medicine unusable, by marking it as "deactivated" in the verification system. Deactivation is performed when the medicine is dispensed to the patient or when it is destroyed.

this directive prevents the entry of falsified medicines into the supply chain. It requires, in particular, the use of a unique identifier and an anti-tampering device on each medicine box and the establishment of a medicines verification system at the national and European level.

system that ensures that the medicine box (outer packaging) has not been opened or tampered with. The anti-tampering device is checked visually before the medicine is dispensed to the patient.

European organization that represents pharmaceutical supply chain stakeholders, responsible for the development and maintenance of the European Medicines Verification System (EMVS).

European medicines verification system. It ensures the authenticity of pharmaceutical products and prevents the entry of falsified medicines into the legal supply chain.

French organization responsible for implementing and managing the medicines verification system in France, in compliance with European Directive 2011/62.

unique code that is placed on each medicine box. It contains information about the product, batch, expiration date and serial number.

national organization responsible for implementing and managing the national medicines verification system in each member country of the European Union.

national medicines verification system. It is connected to the European center and allows pharmacists to verify and deactivate medicines in accordance with the law.

temporary status of a serialized medicine box whose unique identifier could not be verified or deactivated correctly during a scan operation. The box is then set aside, pending resolution of the problem or return of the product to the manufacturer. Quarantine prevents the medicine from being dispensed to the patient or destroyed without having been authenticated.

process that assigns a unique identifier to each medicine box, which is then printed in the form of a DataMatrix code on the packaging. Serialization ensures the traceability and authenticity of medicines.

action that consists of scanning the DataMatrix code of a medicine and comparing it with the data stored in the verification system. Verification ensures that the medicine is not falsified or expired.